NDC 0591-3178 - Citalopram Hydrobromide

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 0591-3178
Package NDCs from labels: 0591-3178-01, 0591-3178-05, 0591-3178-44
Manufacturer: Contract Pharmacy Services-PA
Effective date: 2010-02-25
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
Citalopram Hydrobromide - Contract Pharmacy Services-PA	Contract Pharmacy Services-PA	2010-02-25	HUMAN PRESCRIPTION DRUG LABEL
Citalopram Hydrobromide - Watson Laboratories, Inc	Watson Laboratories, Inc	2008-01-17	HUMAN PRESCRIPTION DRUG LABELING

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
0591-3178-01	Citalopram Hydrobromide	100 in 1 BOTTLE	TABLET	100	4
0591-3178-05	Citalopram Hydrobromide	500 in 1 BOTTLE	TABLET	500	4
0591-3178-44	Citalopram Hydrobromide	100 in 1 BLISTER PACK	TABLET	100	4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0591-3178	CITALOPRAM HYDROBROMIDE (CITALOPRAM HYDROBROMIDE) TABLET [WATSON LABORATORIES, INC]	4	3 package rows	20080125_AFA26CDE-E512-48D1-A9AE-3E1CEE2F7F72.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CITALOPRAM HYDROBROMIDE	ACTIVE INGREDIENT	I1E9D14F36	CITALOPRAM HYDROBROMIDE (CITALOPRAM HYDROBROMIDE) TABLET [WATSON LABORATORIES, INC]	4
CITALOPRAM	ACTIVE MOIETY	0DHU5B8D6V	CITALOPRAM HYDROBROMIDE (CITALOPRAM HYDROBROMIDE) TABLET [WATSON LABORATORIES, INC]	4
corn starch	INACTIVE INGREDIENT		CITALOPRAM HYDROBROMIDE (CITALOPRAM HYDROBROMIDE) TABLET [WATSON LABORATORIES, INC]	4
croscarmellose sodium	INACTIVE INGREDIENT		CITALOPRAM HYDROBROMIDE (CITALOPRAM HYDROBROMIDE) TABLET [WATSON LABORATORIES, INC]	4
hypromellose	INACTIVE INGREDIENT		CITALOPRAM HYDROBROMIDE (CITALOPRAM HYDROBROMIDE) TABLET [WATSON LABORATORIES, INC]	4
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CITALOPRAM HYDROBROMIDE (CITALOPRAM HYDROBROMIDE) TABLET [WATSON LABORATORIES, INC]	4
MANNITOL	INACTIVE INGREDIENT	3OWL53L36A	CITALOPRAM HYDROBROMIDE (CITALOPRAM HYDROBROMIDE) TABLET [WATSON LABORATORIES, INC]	4
microcrystalline cellulose	INACTIVE INGREDIENT		CITALOPRAM HYDROBROMIDE (CITALOPRAM HYDROBROMIDE) TABLET [WATSON LABORATORIES, INC]	4
polyethylene glycol	INACTIVE INGREDIENT		CITALOPRAM HYDROBROMIDE (CITALOPRAM HYDROBROMIDE) TABLET [WATSON LABORATORIES, INC]	4
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	CITALOPRAM HYDROBROMIDE (CITALOPRAM HYDROBROMIDE) TABLET [WATSON LABORATORIES, INC]	4
CITALOPRAM HYDROBROMIDE	ACTIVE INGREDIENT	I1E9D14F36	CITALOPRAM HYDROBROMIDE TABLET [CONTRACT PHARMACY SERVICES-PA]	1
CITALOPRAM	ACTIVE MOIETY	0DHU5B8D6V	CITALOPRAM HYDROBROMIDE TABLET [CONTRACT PHARMACY SERVICES-PA]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	CITALOPRAM HYDROBROMIDE TABLET [CONTRACT PHARMACY SERVICES-PA]	1
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	CITALOPRAM HYDROBROMIDE TABLET [CONTRACT PHARMACY SERVICES-PA]	1
HYPROMELLOSE	INACTIVE INGREDIENT	3NXW29V3WO	CITALOPRAM HYDROBROMIDE TABLET [CONTRACT PHARMACY SERVICES-PA]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CITALOPRAM HYDROBROMIDE TABLET [CONTRACT PHARMACY SERVICES-PA]	1
MANNITOL	INACTIVE INGREDIENT	3OWL53L36A	CITALOPRAM HYDROBROMIDE TABLET [CONTRACT PHARMACY SERVICES-PA]	1
POLYETHYLENE GLYCOL	INACTIVE INGREDIENT	3WJQ0SDW1A	CITALOPRAM HYDROBROMIDE TABLET [CONTRACT PHARMACY SERVICES-PA]	1
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	CITALOPRAM HYDROBROMIDE TABLET [CONTRACT PHARMACY SERVICES-PA]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	CITALOPRAM HYDROBROMIDE TABLET [CONTRACT PHARMACY SERVICES-PA]	1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 14 of 108 · 2,147 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
cle de peau BEAUTE THE FOUNDATION N M O20	OCTINOXATE AND TITANIUM DIOXIDE	Shiseido Americas Corporation	9507f6d1-c11c-428d-8d95-b436f27ba26a	2026-02-24	Warnings	Exact identifier unii: 15FIX9V2JP
Perfect Mineral Sunscreen	TITANIUM DIOXIDE, ZINC OXIDE	SKIN PERFECT MEDICAL	4b93538a-3b3e-90f7-e063-6294a90ab898	2026-02-24	Warnings	Exact identifier unii: 15FIX9V2JP
ANTI-AGING TINTED SUNSCREEN	TITANIUM DIOXIDE, ZINC OXIDE	LASER GIRL SKINCARE, LLC	4b93cd22-1289-29bc-e063-6294a90ab781	2026-02-24	Warnings	Exact identifier unii: 15FIX9V2JP
ANTI-AGING TINTED SUNSCREEN	TITANIUM DIOXIDE, ZINC OXIDE	LASER GIRL SKINCARE, LLC	4b943d72-dcde-e2e4-e063-6294a90ab7c4	2026-02-24	Warnings	Exact identifier unii: 15FIX9V2JP
ANTI-AGING NON-TINTED SUNSCREEN	TITANIUM DIOXIDE, ZINC OXIDE	LASER GIRL SKINCARE, LLC	4b946c39-718b-d70e-e063-6394a90a0db8	2026-02-24	Warnings	Exact identifier unii: 15FIX9V2JP
SHISEIDO URBAN ENVIRONMENT MINERAL CLEAR SUNSCREEN	TITANIUM DIOXIDE, ZINC OXIDE	Shiseido Americas Corporation	b93f10dc-193d-4cda-94b6-3f0e54d89f21	2026-02-23	Warnings	Exact identifier unii: 15FIX9V2JP
SHISEIDO ULTIMATE SUN PROTECTOR MINERAL	TITANIUM DIOXIDE AND ZINC OXIDE	SHISEIDO AMERICAS CORPORATION	5e31eee8-6532-47ea-99fc-22418791804b	2026-02-23	Warnings	Exact identifier unii: 15FIX9V2JP
Perfect Mineral Sunscreen	TITANIUM DIOXIDE, ZINC OXIDE	SKIN PERFECT MEDICAL	4b47e7cb-17d6-6a7c-e063-6294a90abbea	2026-02-20	Warnings	Exact identifier unii: 15FIX9V2JP
Allay Skin Solutions Protect Nourish Mineral Sunscreen SPF 42	TITANIUM DIOXIDE, ZINC OXIDE	ALLAY SKIN SOLUTIONS LLC	425bf1d7-f2cf-4237-9047-dd53054acd1c	2026-02-18	Warnings	Exact identifier unii: 15FIX9V2JP
Hermes Plein Air-Baume de Teint Perfecteur Naturel-Enhancing Complexion Balm 85 TAMARIN	TITANIUM DIOXIDE	S.A. COMPTOIR NOUVEAU DE LA PARFUMERIE	dacff3dc-49d7-6416-e053-2a95a90a85c6	2026-02-18	Warnings	Exact identifier unii: 15FIX9V2JP
Citalopram	CITALOPRAM	Major Pharmaceuticals	a6949652-b15b-435b-9097-2219f398ac05	2026-02-18	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 283672 rxcui: 200371 unii: I1E9D14F36
Alumier MD Clear Shield Broad Spectrum SPF 42 Sunscreen	TITANIUM DIOXIDE, ZINC OXIDE	Alumier Labs	a9c970c8-b6e3-b0a1-e053-2a95a90a89c7	2026-02-09	Warnings	Exact identifier unii: 15FIX9V2JP
Hampton Sun SPF 50 Mineral	ZINC OXIDE 19.5% TITANIUM DIOXIDE 4.00%	S&C Hampton Sun LLC	d6c33436-042e-44e8-8b55-98be6e246879	2026-02-06	Warnings	Exact identifier unii: 15FIX9V2JP
SHISEIDO WASO COLOR-SMART DAY MOISTURIZER	OCTINOXATE, TITANIUM DIOXIDE	Shiseido Americas Corporation	f291f077-1c72-48fc-bb19-c20bdeaaa596	2026-02-06	Warnings	Exact identifier unii: 15FIX9V2JP
SHISEIDO WASO COLOR-SMART DAY MOISTURIZER	OCTINOXATE, TITANIUM DIOXIDE	Shiseido Americas Corporation	54f63dd8-e77f-42e4-a6d3-61ab7beecf50	2026-02-06	Warnings	Exact identifier unii: 15FIX9V2JP
Citalopram	CITALOPRAM	Chartwell RX, LLC	b1f0c6e8-85eb-4368-8709-9cace32415cb	2026-02-06	Boxed warning, Warnings, Adverse reactions	Exact identifier unii: I1E9D14F36
SEYTU Body Sunscreen	TITANIUM DIOXIDE AND ZINC OXIDE	Omnilife USA, Inc.	c411e9a6-b2ea-446b-a886-b92c61736e6c	2026-02-05	Warnings	Exact identifier unii: 15FIX9V2JP
SEYTU Facial Sunscreen	TITANIUM DIOXIDE AND ZINC OXIDE	Omnilife USA, Inc.	96fd37fb-c3ff-413f-b2c8-50754f320ecc	2026-02-05	Warnings	Exact identifier unii: 15FIX9V2JP
No7 Restore and Renew Multi Action Serum Foundation Sunscreen Broad Spectrum SPF 20 Bamboo	OCTINOXATE, TITANIUM DIOXIDE	BCM Cosmetique SAS	ebfe03e7-614f-44b1-b1f1-78edc7e274cc	2026-02-05	Warnings	Exact identifier unii: 15FIX9V2JP
Citalopram	CITALOPRAM	Torrent Pharmaceuticals Limited	04766f1d-7a69-49ed-8fd3-1a6305505d47	2026-02-04	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 283672 rxcui: 200371 rxcui: 309314 unii: I1E9D14F36

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.